Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
18304519 | Compositions and Methods for Treating Spinal Muscular Atrophy | A61K | Apr 20, 2023 | |
18303353 | MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION | A61K, C07K | Apr 18, 2023 | |
18302759 | SYSTEMS AND METHODS FOR CONTROLLING OXYGEN LEVELS | G01N, G01R | Apr 17, 2023 | |
18300834 | ANTI-CD38 ANTIBODIES AND FORMULATIONS | C07K, A61K | Apr 13, 2023 | |
18299640 | USE OF AN IRAK4 MODULATOR FOR GENE THERAPY | A61K, C12N, C07K | Apr 11, 2023 | |
18299632 | USE OF IRAK4 MODULATORS FOR GENE THERAPY | A61K | Apr 11, 2023 | |
18299656 | DENDRITIC CELL ASSAY FOR INNATE IMMUNOGENICITY TO GENE THERAPY AGENTS | C12N, A61K | Apr 11, 2023 | |
18297133 | CONTAINER FOR AN INJECTABLE MEDICAMENT | A61M | Apr 6, 2023 | |
18296088 | Drug Delivery Device | A61M | Apr 4, 2023 | |
18188176 | ANALYTICAL ULTRACENTRIFUGATION FOR CHARACTERIZATION OF RECOMBINANT VIRAL PARTICLES | C12N, G01N | Mar 21, 2023 | |
18186731 | Pharmaceutical Recombinant Human Acid Sphingomyelinase Compositions and Methods | A61P, C12N, B01D | Mar 19, 2023 | |
18183107 | TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF | C07K, A61P, C12N | Mar 12, 2023 | |
18119201 | GENE THERAPY FOR NIEMANN-PICK DISEASE TYPE A | A61K, C12N | Mar 7, 2023 | |
18179890 | RESIDUAL SEMI-RECURRENT NEURAL NETWORKS | G01N, G06N | Mar 6, 2023 | |
18178692 | SYSTEM AND METHOD FOR SUPPORTING ON THE USE OF AN INJECTION DEVICE | G16H | Mar 5, 2023 | |
18174582 | DRIVE MECHANISM FOR AN INJECTION DEVICE | A61M | Feb 23, 2023 | |
18174575 | METHODS OF PROCESSING A FLUID | C07K, B01D | Feb 23, 2023 | |
18172294 | Acoustic Detection of a Usage of an Injection Device | G01F, A61M | Feb 20, 2023 | |
18169779 | VARIANT RNAi | C12N, A61K, A61P | Feb 14, 2023 | |
18104344 | Trigger Arrangement for an Infusion Device | A61M | Jan 31, 2023 |